The Curosurf story is a tale of success. To date, the drug has saved the lives of around one million premature babies worldwide. And the story is far from over. Despite being 73, Tore Curstedt returns to the lab every day - the lab where he has developed a new variant of a drug that is set to help many more babies in the future.

Many years’ research has led Mats Wahlgren to a possible first drug treatment for acute manifestations of sickle cell anemia - a genetic condition that affects millions of people.

Oncopeptides has a new drug candidate for the treatment of a form of cancer of the blood, multiple myeloma, under development. KI Innovations played a key role in getting the project underway.

Aprea Therapeutics AB is working on the development of a new p53-based treatment for cancer. Klas Wiman is one of the company’s founders, and he draws a clear distinction between the roles of researcher and entrepreneur.

Biobank Cellaviva offers parents-to-be the chance to store stem cells  from umbilical cord blood and tissue at birth. Experiences from stem  cell management have now led to the development of one of Sweden’s  first cell therapy drug treatments.